Yourway
6681 Snowdrift Road
Allentown, PA 18106
United States
Office:
Yourway
6681 Snowdrift Road
Allentown, PA 18106
United States
Windtree Therapeutics, Inc. announced that it has dosed the first patient in its phase II study of istaroxime in patients experiencing early cardiogenic shock. Early cardiogenic shock is one of two developmental programs for istaroxime, with the other program targeting acute heart failure, which is supported by positive phase IIOa and IIb trial results and a FDA Fast Track designation. Fast Track programs put an extra strain on clinical trials logistics, but Yourway is prepared for such challenges.
Back to IndexJoin our newsletter mailing list to never miss an update!
Precision in Pharma Supply Chain Summit Boston
November 16-17, 2026
Boston, MA
SCOPE Supply Chain & Logistics Leadership Summit
March 1-4, 2027
Orlando, FL